Successful Treatment of Alopecia Areata With One JAK Inhibitor After Failure of Other JAK Inhibitors

JAMA Dermatology

Clinical Summary

View source

What was studied

An observational report on patients with alopecia areata treated with a different JAK inhibitor after failing other JAK inhibitors.

Study limitations

The abstract provides no sample size, outcomes, or specific drug details, and the observational design is not further specified.

Clinical implications

For alopecia areata nonresponders to one JAK inhibitor, a trial of a different JAK inhibitor may still be effective, based on this observational report.